Non-prescription medicines
Non-prescription medicines can be purchased without a prescription from a doctor or other health professional.
Non-prescription medicines can be bought off the shelf from supermarkets, health food shops or over the counter from pharmacies, depending on their level of risk.
Non-prescription medicines are entered on the Australian Register of Therapeutic Goods (ARTG) as either listed, assessed listed or registered medicines. This is based on their level of risk to the consumer, determined by the ingredients they contain and their intended use (therapeutic indications).
All non-prescription medicines must be manufactured in a licensed or approved facility according to good manufacturing practice (GMP) principles.
Some non-prescription medicines are commonly referred to as complementary medicines.
Listed medicines
- Lowest risk non-prescription medicines.
- Have ‘AUST L’ on the label.
- Not individually evaluated by the TGA for quality, safety and efficacy before they are supplied in the marketplace.
- Ingredients are selected from a TGA pre-approved ingredients list.
- More information about listed medicines.
Assessed listed medicines
- Lower risk non-prescription medicines.
- Have ‘AUST L(A)’ on the label.
- Therapeutic indications have been assessed by the TGA for efficacy before they are supplied in the marketplace.
- Ingredients are selected from a TGA pre-approved ingredients list.
- Can use the ‘TGA assessed’ claim on their label.
- More information about assessed listed medicines.
Registered non-prescription medicines
- Higher risk non-prescription medicines.
- Have ‘AUST R’ on the label.
- TGA performs a full pre-market evaluation of their safety, quality and efficacy before they are supplied in the market.
- Two main types of registered non-prescription medicines:
- Over the counter (OTC) medicines, such as pain relief, antihistamines, nicotine replacement therapy.
- Registered complementary medicines, such as higher dose iron supplements.
- Registered complementary medicines can use the ‘TGA assessed’ claim on their label.
Latest alerts
- Medicines containing turmeric or curcumin - risk of liver injuryThe TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.
- Health supplements containing vitamin B6 can cause peripheral neuropathyBEWARE - Health supplements containing vitamin B6 can cause peripheral neuropathy
Latest articles
- Changes to choline salicylate access to start from 1 October 2023Find out about changes to choline salicylate access, starting from October 2023.
- Update to listed medicine ingredients in July 2023Find out how listed medicine ingredients, and requirements for their use, have been updated in the latest Therapeutic Goods (Permissible Ingredients) Determination.
- GMP Clearance: Extension processing timesDelays in processing timeframes of applications to extend GMP Clearances.
Latest publications
- Public notice of interim decisions on proposed amendments to the Poisons Standard - ACMS#40, ACCS#35, Joint ACMS-ACCS#32 - November 2022Interim decisions and invitation for further comment. Closing date: 3 March 2023
- Pharmacovigilance Inspection Program metrics report: Jan - Dec 2021The TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
- PIC/S Guide to GMP: Manufacturing principles for medicinal productsPIC/S Guide to Good Manufacturing Practice (GMP) for Medicinal Products, PE009-15, 01 May 2021: Current version